Home Knowledge Base Tate & Lyle

Tate & Lyle

No mentions found

This entity hasn't been tracked yet, or Iris is still building its knowledge base.

Related Articles from SNS

Ingredion Is in Advanced Talks to Acquire Tate & Lyle for £2.7 billion

Tate & Lyle produces a range of ingredients used in everything from baked goods to animal feed. Source: Tate & Lyle Plc

Bloomberg Markets 2d ago

Ingredion CEO Says Tate & Lyle Deal Creates Powerhouse

Ingredion Inc. agreed to buy Tate & Lyle Plc for £2.7 billion ($3.6 billion), and will end the UK company’s near-century listing on the London Stock Exchange. Ingredion Chief Executive Officer James Zallie says the US company paid a "fair" premium and this deal creates an ingredients "powerhouse." He speaks on "Bloomberg The Close."

Bloomberg Markets 1d ago

Tate & Lyle Latest Loss for London After Sale to US Rival

Tate & Lyle focuses on sugar replacements and calorie reducers, and is also pushing into various dietary fibers.

Bloomberg Markets 2d ago

Tate & Lyle agrees £2.7bn takeover by US rival in new blow to London market

Venerable but struggling UK firm backs deal with Chicago-based Ingredion putting nearly 500 jobs worldwide at riskTate & Lyle has agreed to a £2.7bn takeover by its US rival Ingredion, in a deal that could put hundreds of jobs at risk and represents yet another loss for London’s struggling stock market. The FTSE 250 business, which makes artificial sweeteners such as Splenda, has agreed to a deal that values it at 615p per share, about 60% above its price before news of a possible...

The Guardian UK 2d ago

Tate & Lyle agrees £2.7bn takeover by US rival in new blow to London market

Venerable but struggling UK firm backs deal with Chicago-based Ingredion putting nearly 500 jobs worldwide at riskTate & Lyle has agreed to a £2.7bn takeover by its US rival Ingredion, in a deal that could put hundreds of jobs at risk and represents yet another loss for London’s struggling stock market. The FTSE 250 business, which makes artificial sweeteners such as Splenda, has agreed to a deal that values it at 615p per share, about 60% above its price before news of a possible...

The Guardian Business 2d ago

Tate & Lyle agrees £2.7bn takeover by US rival in new blow to London market

Venerable but struggling UK firm backs deal with Chicago-based Ingredion putting nearly 500 jobs worldwide at riskTate & Lyle has agreed to a £2.7bn takeover by its US rival Ingredion, in a deal that could put hundreds of jobs at risk and represents yet another loss for London’s struggling stock market. The FTSE 250 business, which makes artificial sweeteners such as Splenda, has agreed to a deal that values it at 615p per share, about 60% above its price before news of a possible...

The Guardian World 2d ago

Tate & Lyle agrees to £2.7bn takeover from US rival Ingredion

Takeover of long-serving FTSE member deepens London stock market malaise

Financial Times 2d ago